New application of tetrandrine in fungal bio-film resistance

A technology of tetrandrine and biofilm, applied in the field of medicine

Inactive Publication Date: 2012-09-19
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF3 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] We found that tetrandrine used alone in vitro can effectively inhibit the growth and proliferation of fungal biofilms, an...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New application of tetrandrine in fungal bio-film resistance
  • New application of tetrandrine in fungal bio-film resistance
  • New application of tetrandrine in fungal bio-film resistance

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] Example 1: The effect of Tetrandrine alone on the biofilm of different Candida albicans strains.

[0015] Materials and methods

[0016] 1. Test drug

[0017] Tetrandrine: purchased from Sigma Company.

[0018] Fluconazole: purchased from Sigma Company.

[0019] Amphotericin B: purchased from Sangon Bioengineering Co., Ltd.

[0020] XTT: purchased from Sigma Corporation.

[0021] Menadione (menadione): purchased from Sigma Company.

[0022] Dimethyl sulfoxide (DMSO): China Pharmaceutical (Group) Shanghai Chemical Reagent Company, redistilled before use.

[0023] Acetone: purchased from Sigma Company.

[0024] Tetrandrine was made into 6.4 mg / ml and 12.8 mg / ml solutions with dimethyl sulfoxide, amphotericin B was made into 4 mg / ml solution with dimethyl sulfoxide, and fluconazole was made into 102.4 mg with dimethyl sulfoxide / ml solution, the test drug was stored at -20°C. Before the experiment, the drug stock solution was taken out and melted in a 35°C incubat...

Embodiment 2

[0056] Embodiment 2: the effect of tetrandrine (also known as tetrandrine) alone on the biofilm of different Cryptococcus neoformans strains

[0057] Materials and methods

[0058] 1. Test drug

[0059] Tetrandrine: purchased from Sigma Company.

[0060] Fluconazole: purchased from Sigma Company.

[0061] Amphotericin B: purchased from Sangon Bioengineering Co., Ltd.

[0062] XTT: purchased from Sigma Corporation.

[0063] Menadione (menadione): purchased from Sigma Company.

[0064] Dimethyl sulfoxide (DMSO): China Pharmaceutical (Group) Shanghai Chemical Reagent Company, redistilled before use.

[0065] Acetone: purchased from Sigma Company.

[0066] Tetrandrine was made into 6.4mg / ml and 12.8mg / ml with dimethyl sulfoxide, amphotericin B was made into 4mg / ml with dimethyl sulfoxide, and fluconazole was made into 102.4mg / ml with dimethyl sulfoxide , and the test drug was stored at -20°C. Before the experiment, the drug stock solution was taken out and melted in a 35°...

Embodiment 3

[0097] Embodiment 3: the effect of tetrandrine (also known as tetrandrine) alone on the biofilm of different Aspergillus strains

[0098] Materials and methods

[0099] 1. Test drug

[0100] Tetrandrine: purchased from Sigma Company.

[0101] Fluconazole: purchased from Sigma Company.

[0102] Amphotericin B: purchased from Sangon Bioengineering Co., Ltd.

[0103] XTT: purchased from Sigma Corporation.

[0104] Menadione (menadione): purchased from Sigma Company.

[0105] Dimethyl sulfoxide (DMSO): China Pharmaceutical (Group) Shanghai Chemical Reagent Company, redistilled before use.

[0106] Acetone: purchased from Sigma Company.

[0107] Tetrandrine was made into 6.4mg / ml and 12.8mg / ml with dimethyl sulfoxide, amphotericin B was made into 4mg / ml with dimethyl sulfoxide, and fluconazole was made into 102.4mg / ml with dimethyl sulfoxide , and the test drug was stored at -20°C. Before the experiment, the drug stock solution was taken out and melted in a 35°C incubator,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses new application of tetrandrine in fungal bio-film resistance, and relates to application of tetrandrine in the field of fungal bio-film resisting treatment medicaments. The tetrandrine compound has the following chemical structural formula; and experimental results show that the tetrandrine compound has high fungal bio-film resisting activity in vitro. Experimental results show that the tetrandrine can effectively inhibit growth and proliferation of the fungal bio-films in vitro and effectively inhibit mature bio-films.

Description

Technical field: [0001] The invention relates to the technical field of medicine, and relates to a new application of tetrandrine (also known as tetrandrine) in antifungal biofilms. Background technique: [0002] Tetrandrine (also known as tetrandrine) is derived from the root of Stephania tetrandra S. Moore, a plant of the Tetradaceae family. Its structure is shown in formula (I), and it is a colorless needle-like crystal with a melting point of 217-218°C , It is mainly used clinically to treat early mild hypertension. It has been reported that tetrandrine (also known as tetrandrine) has a synergistic effect on fluconazole against Candida albicans (Li Fengxia, Zhang Hong, Synergistic effect of tetrandrine on fluconazole anti-Candida albicans, Zhonghua Journal of Dermatology, 2006, 39 (8): 454-456), but there is no report on the antifungal biofilm research of tetrandrine (also known as tetrandrine) alone. [0003] [0004] Biofilm is a microbial aggregation group, which...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A01N43/90A01P3/00
Inventor 王彦赵兰雪李德东曹永兵阎澜姜远英
Owner SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap